BELLUS Health, Inc. (NASDAQ: BLUS), a global health company, is committed to developing and commercializing products that provide innovative health solutions to address substantial, but unmet needs. The company’s wholly owned subsidiary, OVOS Natural Health Inc., aims to develop a strong franchise with several products marketed to help brain function as well as expand to other conditions. For further information, visit the Company’s web site at www.bellushealth.com.
- 17 years ago
QualityStocks
BELLUS Health, Inc. (NASDAQ: BLUS)
Tags Rodman & Renshaw
Related Post
-
Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation
Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Delivers Critical Security and Defense Solutions to Governments and Organizations
Safe Pro Group delivers AI, drone-based services, and ballistic protective gear, to customers in the…
-
LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Oncology Landscape
Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…